leisure time -WSS

leisure time

author：leisure time 2025-09-30 12:08:10 - browse：594

illustration of one blue dna strand — Adobe

The Food and Drug Administration is convening a meeting of outside experts on Tuesday to review exa-cel, a CRISPR-based treatment for sickle cell disease made by Vertex Pharmaceuticals and CRISPR Therapeutics.

Tuesday’s meeting is set up a bit differently than most FDA advisory panels. The agency has not raised any concerns about exa-cel’s efficacy or safety, and there will not be a typical vote at the end of the day on whether the data from exa-cel’s pivotal clinical trial support an approval as a treatment for sickle cell disease.

Instead, the FDA is seeking input about the methods used by Vertex and CRISPR Therapeutics to evaluate the risk of inadvertently making unwanted changes to patients’ DNA — so-called off-target editing — when exa-cel is administered.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Sophia Smith scores twice for US in in 3

WSS

Severe heat forecast: Where scorching temperatures will persist over the next week

Antibiotic resistance and the global rise in human conflict

FAMU bans football players from facility after release of rap video shot in team's locker room

Burning questions for the 2024 JPM Healthcare Conference

3 medical device trends to watch in 2024

Men with early prostate cancer can safely opt out of treatment

Wikipedia

leisure time

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

3 trends to watch in health tech's hiring outlook for 2024

In Memoriam: Notable people who died in 2023

White House finalizes ITC's import ban of latest Apple Watches

Medical records are filled with copy

JPM: CVS says Medicare Advantage patients are impacting profits

United colonoscopy coverage change 'may cost lives,' doctors say

Statins reduce cardiovascular risk in people living with HIV

Moonlake's readout produced a cash windfall. Risks remain

New weight loss drugs work. But how can they best be used?

entertainment

Goldman Sachs launches $650M fund for life science investments

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

JPM: CVS says Medicare Advantage patients are impacting profits

Malaysia cuts short music fest after British band slams anti

Doctors have an ethical obligation to be advocates

3 medical device trends to watch in 2024

knowledge

Wikipedia

Wikipedia

Wikipedia